Annual growth rate of MS treatment value in China 2018-2028
In 2022, the value of multiple sclerosis (MS) treatments performed in China saw an annual growth rate of about 8.2 percent. The annual growth rate increased gradually since 2018, and was estimated to reach 8.5 percent in 2028.